Affiliation:
1. From the Department of Surgery of New York Hospital-Cornell Medical Center, the Department of Microbiology of New York University, and Rockefeller University, New York, New York.
Abstract
Indirect immunofluorescent techniques used for detection of heart-reactive antibody have been used in both human and experimental cardiac transplantation. Definite evidence is presented which demonstrates the presence of circulating heart-reactive antibody preceding clinical or laboratory evidence of cardiac rejection. In all patients who lived longer than one week and died of cardiac rejection, an increase in titers of heart-reactive antibody were present prior to obvious signs of rejection and death. Immunosuppressive therapy, both experimentally and clinically, has been demonstrated to alter the titer of circulating heart-reactive antibody. Much work is needed to clarify the significance of this heart-reactive antibody in the mechanism of rejection. However, the presence of heart-reactive antibody in patients after cardiac transplantation appears to be a valuable aid in monitoring cardiac rejection.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献